Aripiprazole Discontinuation Strategy in Adults Treated for Depressive Disorders
Gradual, individualized tapering is recommended rather than abrupt cessation of aripiprazole. [1], [2] A slow, stepwise dose reduction over time is recommended to reduce withdrawal, symptom recurrence, and dose-change intolerance. [1], [3]
Medication Taper Principles
Aripiprazole should be tapered under the prescriber’s supervision. [1] Dose reductions should be stepwise rather than an abrupt stop. [1], [3] The taper pace should allow monitoring for recurrence of depressive symptoms and for emergence of activation or insomnia after each dose change. [3]
Medication Selection Algorithm
For discontinuation, the medication selection decision is restricted to continuing the current depression regimen while aripiprazole is reduced. [2] If aripiprazole is used as augmentation for depressive symptoms, the primary depression treatment should remain stable during taper unless clinically urgent medication changes are required. [2]
Tapering Schedule for a 5 mg Daily Dose
A general rule of thumb for gradual dose reduction is to reduce the antipsychotic dose by approximately 25% every 4 weeks, with reassessment after each reduction before proceeding. [4] For a 5 mg daily dose, this rule of thumb can be operationalized as follows (using the smallest practical dose increments available): [4]
- 5 mg daily → ~3.75 mg daily for ~4 weeks, then assess symptoms. [4]
- ~3.75 mg daily → ~2.5 mg daily for ~4 weeks, then assess symptoms. [4]
- ~2.5 mg daily → ~1.25 mg daily for ~4 weeks, then assess symptoms. [4]
- ~1.25 mg daily → discontinue after an additional ~4 weeks if tolerability and mood stability remain adequate. [4]
Initiation Thresholds and Monitoring During Taper
After each dose reduction, monitoring should focus on depressive relapse and emergence of destabilizing symptoms. [4] Dose reduction intervals should be extended if destabilization occurs after a reduction. [3] If clinically significant worsening of depression occurs during the taper, discontinuation should be paused and treatment adjustment should be made promptly. [3]
Common Pitfalls to Avoid
Abrupt discontinuation should be avoided because aripiprazole should not be stopped without prescriber guidance. [1] Tapering should not proceed on a fixed schedule when symptoms worsen after a dose reduction. [3]
Targets and Goals of Therapy
The goal of tapering is sustained remission or stable improvement of depressive symptoms without withdrawal-related problems and without relapse during dose-change monitoring intervals. [3], [4]
Safety Considerations Requiring Urgent Clinical Action
Urgent clinical evaluation is required for severe return of depression, suicidal ideation, or other acute psychiatric deterioration occurring during taper. [3]
Source References
[1] MedlinePlus Drug Information: aripiprazole. [1] [2] DailyMed label: aripiprazole adjunctive treatment dose range for patients with depression taking an antidepressant (2 to 5 mg/day). [2] [3] NICE NG215: safe prescribing and withdrawal management for adults (stepwise, slower dose reduction principles when tapering medicines with withdrawal risk). [3] [4] NCBI Bookshelf Appendix B: general rule of thumb to reduce antipsychotic dose by 25% every 4 weeks with monitoring and waiting at least about a week before next reduction. [4]